These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10954736)

  • 21. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T; Borba VZ; Roberson P; Manolagas SC
    Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.
    Rödel B; Tavassoli K; Karsunky H; Schmidt T; Bachmann M; Schaper F; Heinrich P; Shuai K; Elsässer HP; Möröy T
    EMBO J; 2000 Nov; 19(21):5845-55. PubMed ID: 11060035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The LIM/homeodomain protein Islet1 recruits Janus tyrosine kinases and signal transducer and activator of transcription 3 and stimulates their activities.
    Hao A; Novotny-Diermayr V; Bian W; Lin B; Lim CP; Jing N; Cao X
    Mol Biol Cell; 2005 Apr; 16(4):1569-83. PubMed ID: 15659653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells.
    Taler M; Shpungin S; Salem Y; Malovani H; Pasder O; Nir U
    Mol Endocrinol; 2003 Aug; 17(8):1580-92. PubMed ID: 12738762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
    Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
    J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
    Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
    Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knocking the SOCS off a tumor suppressor.
    Kishimoto T; Kikutani H
    Nat Genet; 2001 May; 28(1):4-5. PubMed ID: 11326261
    [No Abstract]   [Full Text] [Related]  

  • 33. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
    Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Induction of SOCS family proteins in inflammatory diseases and suppression of inflammatory arthritis model by the adenovirus gene transfer].
    Yoshimura A; Shouda T; Yoshida T; Hanada T
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2355-61. PubMed ID: 12518461
    [No Abstract]   [Full Text] [Related]  

  • 35. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
    Flowers LO; Subramaniam PS; Johnson HM
    Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor.
    Yamamoto T; Sato N; Sekine Y; Yumioka T; Imoto S; Junicho A; Fuse H; Matsuda T
    Biochem Biophys Res Commun; 2003 Jun; 306(2):610-5. PubMed ID: 12804609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transducer and activator of transcription 3 activation by the delta-opioid receptor via Galpha14 involves multiple intermediates.
    Lo RK; Wong YH
    Mol Pharmacol; 2004 Jun; 65(6):1427-39. PubMed ID: 15155836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.